Senate Subcommittee Probes FDA Withdrawal of 2 COVID-19 Vaccine Studies on June 3
Updated
Updated · legis1.com · Jun 2
Senate Subcommittee Probes FDA Withdrawal of 2 COVID-19 Vaccine Studies on June 3
3 articles · Updated · legis1.com · Jun 2
Summary
June 3 is the date set for a Senate Permanent Subcommittee on Investigations hearing into whether FDA officials suppressed COVID-19 vaccine safety research by ordering two accepted studies withdrawn from journals.
May 5 reports said the papers had been accepted by Drug Safety and Vaccine before the FDA intervened; HHS later confirmed the withdrawals, saying the authors' conclusions were broader than the data supported.
Ron Johnson's panel has already made vaccine-safety oversight a central line of attack, releasing about 600 pages of records in May and holding a separate hearing accusing Biden-era officials of ignoring safety signals.
Democrats on the subcommittee are expected to challenge whether the episode reflects legitimate scientific quality control or a politicized effort that could further damage trust in vaccines and federal health agencies.
If withdrawn vaccine studies were reassuring, why would health officials block their publication?
When does scientific quality control cross the line into censorship of taxpayer-funded research?
How can public trust in science be rebuilt when experts and agencies publicly clash?
2026 Senate Investigation: FDA Blocks Publication of COVID and Shingles Vaccine Safety Studies Amid Administration’s Anti-Vaccine Shift
Overview
On June 3, 2026, the Senate Permanent Subcommittee on Investigations, led by Senator Ron Johnson, held a major hearing to examine controversial FDA actions, particularly the withdrawal of studies affirming vaccine safety. Senator Johnson described the FDA’s moves as corruption and stressed his goal to expose the truth for the American public. The hearing highlighted deep divisions over vaccine policy, with Johnson’s investigative approach aiming to bring transparency. This event reflects growing political and scientific tensions, as the FDA’s decisions and the administration’s skepticism toward established vaccine science have sparked widespread debate and concerns about public trust.